| Cost of disorders of the brain in Europe 2010 | European Neuropsychopharmacology | 2011 | 987 |
| The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease | Movement Disorders | 2011 | 594 |
| Screening for fetal aneuploidies at 11 to 13 weeks | Prenatal Diagnosis | 2011 | 394 |
| p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS | Acta Neuropathologica | 2011 | 369 |
| Hepatitis delta virus | Lancet, The | 2011 | 351 |
| A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q | Blood | 2011 | 348 |
| The Charcot foot in diabetes | Diabetes Care | 2011 | 317 |
| Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks | Prenatal Diagnosis | 2011 | 312 |
| Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks | Prenatal Diagnosis | 2011 | 291 |
| Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data | Gut | 2011 | 274 |
| Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients | Journal of Neurology, Neurosurgery and Psychiatry | 2011 | 271 |
| Parkinson's disease: the non-motor issues | Parkinsonism and Related Disorders | 2011 | 258 |
| EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease | European Heart Journal | 2011 | 255 |
| Turning the pyramid of prenatal care | Fetal Diagnosis and Therapy | 2011 | 245 |
| Increasing burden of liver disease in patients with HIV infection | Lancet, The | 2011 | 215 |
| Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing | PLoS ONE | 2011 | 215 |
| Parkinson's disease sleep scale--validation of the revised version PDSS-2 | Movement Disorders | 2011 | 198 |
| Intensive care of the patient with cirrhosis | Hepatology | 2011 | 186 |
| Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature | International Journal of Clinical Practice | 2011 | 184 |
| Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation | British Journal of Haematology | 2011 | 176 |
| Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis | Journal of Hepatology | 2011 | 173 |
| Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis | American Journal of Respiratory and Critical Care Medicine | 2011 | 170 |
| Biliary atresia in England and Wales: results of centralization and new benchmark | Journal of Pediatric Surgery | 2011 | 169 |
| EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease | Journal of the American Society of Echocardiography | 2011 | 161 |
| Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking | Clinical and Experimental Dermatology | 2011 | 160 |
